Helicobacter Pylori Management in Primary Care

Overview

Journal Intern Emerg Med

Publisher Springer

Specialties Emergency Medicine
General Medicine

Date 2011 Sep 23

PMID 21938548

Authors

Mario M DElios

Elena Silvestri

Giacomo Emmi

Aija Zilevica

Domenico Prisco

Affiliations

Soon will be listed here.

References

Hunt R, Bazzoli F . Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment Pharmacol Ther. 2004; 19 Suppl 1:9-16. DOI: 10.1111/j.0953-0673.2004.01830.x. View

DElios M, Amedei A, Manghetti M, Costa F, Baldari C, Quazi A . Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. Gastroenterology. 1999; 117(5):1105-12. DOI: 10.1016/s0016-5085(99)70395-1. View

Sung J . Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?. Aliment Pharmacol Ther. 2004; 20 Suppl 2:65-70. DOI: 10.1111/j.1365-2036.2004.02041.x. View

Zullo A, Hassan C, Oliveti D, Chiriatti A, Chiuri D, Marotti G . Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care. Intern Emerg Med. 2011; 7(4):331-5. DOI: 10.1007/s11739-011-0578-7. View

Wotherspoon A, Doglioni C, Diss T, Pan L, Moschini A, de Boni M . Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993; 342(8871):575-7. DOI: 10.1016/0140-6736(93)91409-f. View

Graham D, Chan F . NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology. 2008; 134(4):1240-6. DOI: 10.1053/j.gastro.2008.02.007. View

Malfertheiner P, Megraud F, OMorain C, Bazzoli F, El-Omar E, Graham D . Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2006; 56(6):772-81. PMC: 1954853. DOI: 10.1136/gut.2006.101634. View

. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994; 61:1-241. PMC: 7681621. View

Mahe I, Leizorovicz A, Caulin C, Bergmann J . Aspirin for the prevention of cardiovascular events in the elderly. Drugs Aging. 2003; 20(13):999-1010. DOI: 10.2165/00002512-200320130-00004. View

10.

Salih B, Abasiyanik M, Bayyurt N, Sander E . H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study. World J Gastroenterol. 2007; 13(23):3245-8. PMC: 4436612. DOI: 10.3748/wjg.v13.i23.3245. View

11.

Vergara M, Catalan M, Gisbert J, Calvet X . Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther. 2005; 21(12):1411-8. DOI: 10.1111/j.1365-2036.2005.02444.x. View

12.

Costa F, DElios M . Management of Helicobacter pylori infection. Expert Rev Anti Infect Ther. 2010; 8(8):887-92. DOI: 10.1586/eri.10.75. View

13.

DElios M, Appelmelk B, Amedei A, Bergman M, Del Prete G . Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med. 2004; 10(7):316-23. DOI: 10.1016/j.molmed.2004.06.001. View

14.

Huang J, Sridhar S, Hunt R . Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002; 359(9300):14-22. DOI: 10.1016/S0140-6736(02)07273-2. View